Investigating the role of bcaa metabolism in regulating adiposity during systemic hypoxia
Active Project Grant Awarded Last action
- Award ID
- F30DK139713
- Recipient
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $179,650
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date 53% complete
- Place of performance
- San Francisco, CA 94158, USA
Award details come from USAspending.gov.
Description
- Abstract
- Obesity and increased adiposity contribute to cardiovascular disease and mortality, but high-altitude populations have lower rates of chronic metabolic disease and cardiovascular mortality. In mice, oxygen deprivation recapitulates these effects, lowering body weight, adiposity, and blood glucose levels. Elucidating the mechanisms underlying this metabolic reprogramming can inspire effective therapies for obesity. Untargeted metabolic profiling of adipose tissue from hypoxic mice revealed the enrichment of branched-chain hydroxyacids (bchas), which are understudied derivatives of branched-chain amino acids (bcaas). Notably, impaired bcaa clearance has consistently been associated with obesity and insulin resistance. Understanding the regulation of bcaa metabolism in hypoxia can uncover causal mechanisms linking bcaa metabolism to metabolic health. Hypoxia may promote bcha production by driving a shift in adipocytes from canonical bcaa metabolism to this alternative pathway. Little is known about the regulatory mechanisms that control the metabolic pathway producing bchas. The enzyme that catalyzes bcha production has not been identified, but human genetics data suggests that lactate dehydrogenase a (ldha) expression is associated with bcha levels. Moreover, prior work suggests that the biochemical effects of hypoxia disrupt complexes of canonical bcaa metabolism enzymes, facilitating bcha production through the alternative pathway. In vitro models of adipose tissue hypoxia will be used to determine whether these mechanisms drive hypoxia-induced bcha production (aim 1). Beyond these regulatory mechanisms, the impact of bcha production is not known, but observational data from mice and humans shows that increased bcha production is associated with diminished adiposity. Therefore, bcha production may contribute to the decreased FAT mass in hypoxia. This hypothesis will be tested using bckdk-knockout mice, which exhibit impaired bcha production (aim 2). Measuring adiposity and glucose clearance of these mice in hypoxia will reveal the metabolic role of bcha production in hypoxia. These experiments will elucidate the mechanisms underlying the reprogramming of adipose bcaa metabolism in hypoxia. These experiments will be conducted with the guidance of DR. Isha jain and DR. Andrei goga, both experts in the regulation of cellular metabolism and metabolic physiology. Investigating the causal relationship between bcaa metabolism and metabolic health will inspire new therapeutic approaches for obesity.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $55,114 | |
| Amendment | $41,888 | |
| Amendment | $41,324 | |
| Amendment | $41,324 | |
| Original award | $0 |
Quick answers
Who received award F30DK139713?
F30DK139713 was awarded to The Regents Of The University Of California. San Francisco by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 30, 2024.
How much is award F30DK139713 worth?
$179,650 has been obligated on F30DK139713.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award